Since cancer cells are heavily addicted to glutamine, it is natural to observe that oncogenes, especially KRAS, elevate the genes associated with glutamine catabolism such GLS, GLUD, SLC1A5, transaminase, etc., through Myc, which is the downstream molecule of the oncogenes [116,117,118]. This evidence concerns the gene MYC and cancer.